Jannette Dufour
Member of Scientific Advisory BoardDr. Jannette Dufour PhD has been a Member of Scientific Advisory Board of Sernova Biotherapeutics Inc (formerly known as Sernova Corp.) since August 1, 2006. In 1999 Dr. Dufour received a PhD in Genetics and Cell Biology from Washington State University, where she first began research on Sertoli cells as a graduate student. She then went on to receive further training as a postdoctoral fellow with Drs. Rajotte and Korbutt with the Islet Transplantation Program at the University of Alberta. While there she received five postdoctoral fellowships to study the use of Sertoli cells as a way to immunoprotect transplanted islets. Dr. Dufour is now an Assistant Professor at Texas Tech University Health Sciences Center where she continues to investigate the immunoprotective properties of Sertoli cells with the goal of developing ways to improve the survival of transplanted islets. Currently Assistant Professor in the Department of Cell Biology and Biochemistry at Texas Tech University Health Sciences Center in Lubbock Texas, Dr. Dufour's research was instrumental in developing the technology leading to some of the Sertoli cell patents now licensed exclusively to Pheromone.
Positions
- Company NameSernova Biotherapeutics IncStock CodeSEOVFPositionMember of Scientific Advisory BoardColleagues
- JMJonathan M. N. RigbyPresident, CEO & Director
- JLJohn L. BrooksIndependent Chairman
- JTJames T. ParsonsChief Financial Officer
- MRMarylyn RigbyChief Communications Officer
- DBDavid BurkeVice President of Investor Relations
- PBPatricia BeastonSernova Biotherapeutics Inc.
- RARobert A. GabbayChairman of Clinical Advisory Board
- NCNorman C. W. WongMember of Scientific Advisory Board
